课题基金 / 基金详情

CORNEAL HEALING PROMOTION WITH FIBRONECTIN PEPTIDES

CORNEAL HEALING PROMOTION WITH FIBRONECTIN PEPTIDES
纤连蛋白肽促进角膜愈合
批准号:
3263067
负责人:
LEO T FURCHT
金额:
$11.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-08-01 至 1991-07-31

项目摘要

项目成果

LEO T FURCHT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abnormalities in corneal wound healing are a major health care problem. There are a number of clinical conditions where corneal wound healing is compromised, for example, herpes simplex keratitos, diabetes mellitus, and rheumatoid disease. Cornea healing is also an important complicating factor in various surgical procedures involving the cornea and cateracts. Excessive epithelial migration through a corneal or limbal wound can epithelialize the anterior chamber of the eye and cause secondary glaucoma. Evidence from refractive surgery suggests that corneal scarring can be unpredictable and incomplete. This proposal will examine the ability of fibronectin fragments and chemically synthesized peptides to promote in vitro and in vivo corneal epithelial wound healing in model systems. Fibronectin is a multidomain molecule which is involved in the normal wound healing in the eye. Exogenous FN will promote healing of chronic corneal ulcers. We will isolate specific proteolytic fragments added to an in vitro model to determine whether the rate of healing is increased. The next studies will determine the effects of these fragments or peptides in promoting isolated epithelial cell movement in vitro. To aid in vivo studies, we will next use radiolabelled FN peptides or fragments and determine binding to corneas in vitro in 3 vehicles which may increase peptide exposure in the cornea: polyvinyl alcohol, petrolatum, and hyaluronic acid. The nexty studies will utilize bioactive peptides and fragments of fibronectin in vehicles in in vivo model systems of full and partial thickness wounds. Healing rate will be monitored by evaluating corneal healing serially in animals over 72 hours. Histological samples and morphometric analyses will be performed to confirm the in vivo results. The studies will hopefully provide an effective, safe (avoiding the risk of blood products) method using chemically synthesized peptides to deliver pharmaceuticals which will enhance corneal wound healing. This would also have application for diseases of the eye where there is abnormal wound healing. Modest success in this research program could have a major impact on serious health care problems.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Effects of matrix proteins on rabbit corneal epithelial cell adhesion and migration.
基质蛋白对兔角膜上皮细胞粘附和迁移的影响。
DOI: 10.3109/02713688809047035
发表时间: 1988
期刊: Current eye research
影响因子: 2
作者: [Cameron,JD, Hagen,ST, Waterfield,RR, Furcht,LT]
通讯作者: Furcht,LT
Quantification of corneal organ culture migration: central and peripheral epithelium.
角膜器官培养物迁移的定量:中央和外周上皮。
DOI: --
发表时间: 1989
期刊: Investigative ophthalmology & visual science
影响因子: 4.4
作者: [Cameron,JD, Waterfield,RR, Steffes,MW, Furcht,LT]
通讯作者: Furcht,LT
Epithelial and neural localization and heparin binding of the cell-substratum adhesion molecule, epinectin.
细胞-基质粘附分子表连蛋白的上皮和神经定位以及肝素结合。
DOI: 10.1111/1523-1747.ep12463285
发表时间: 1988
期刊: The Journal of investigative dermatology
影响因子: --
作者: [Enenstein,J, Furcht,LT]
通讯作者: Furcht,LT
TYPE IV COLLAGEN PEPTIDES--RECEPTORS IN CORNEAL FUNCTION
  • 批准号:
    2162677
  • 项目类别:
  • 资助金额:
    $19.45万
  • 财政年份:
    1991
  • 负责人:
    LEO T FURCHT
  • 依托单位:
TYPE IV COLLAGEN PEPTIDES-RECPTORS IN CORNEAL FUNCTION
  • 批准号:
    3266426
  • 项目类别:
  • 资助金额:
    $14.11万
  • 财政年份:
    1991
  • 负责人:
    LEO T FURCHT
  • 依托单位:
TYPE IV COLLAGEN PEPTIDES-RECPTORS IN CORNEAL FUNCTION
  • 批准号:
    3266427
  • 项目类别:
  • 资助金额:
    $17.9万
  • 财政年份:
    1991
  • 负责人:
    LEO T FURCHT
  • 依托单位:
TYPE IV COLLAGEN PEPTIDES-RECPTORS IN CORNEAL FUNCTION
  • 批准号:
    3266424
  • 项目类别:
  • 资助金额:
    $13.98万
  • 财政年份:
    1991
  • 负责人:
    LEO T FURCHT
  • 依托单位:
海外基金